• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型宫腔镜下左炔诺孕酮宫内缓释系统子宫底部非缝合固定术的临床应用

Clinical application of a novel hysteroscopic LNG-IUS non-suture fixation at the uterine fundus.

作者信息

Yu Yi, Zhang Hongwei, Sui Long, Chen Limei

机构信息

Hysteroscopy Centre, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China.

出版信息

Front Med (Lausanne). 2025 Apr 28;12:1563888. doi: 10.3389/fmed.2025.1563888. eCollection 2025.

DOI:10.3389/fmed.2025.1563888
PMID:40357308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12066786/
Abstract

OBJECTIVE

This study aimed to explore the feasibility and clinical effects of a novel hysteroscopic levonorgestrel-releasing intrauterine system (LNG-IUS) non-suture fixation at the uterine fundus.

METHODS

From October 2023 to July 2024, a prospective study involving a novel hysteroscopic LNG-IUS non-suture fixation at the uterine fundus was conducted at Obstetrics and Gynecology Hospital, Fudan University. The patient's clinical symptoms, surgical time, surgical complications, postoperative LNG-IUS expulsion, and other follow-up information were recorded.

RESULTS

A total of 31 patients were included in this study. The average uterine depth is 9.17 ± 0.67 cm. Among them, 10 cases had a history of LNG-IUS expulsion. The average surgical time is 13.0 ± 4.1 min, and the average intraoperative blood loss is 5.3 ± 3.6 mL. All patients did not experience complications such as uterine perforation, massive bleeding, fluid overload, or postoperative infection. The average follow-up time after surgery was 6.0 ± 1.8 months, and no LNG-IUS expulsion occurred. The pain assessment and mean menstrual flow postoperation were less than preoperation, and the endometrial thickness and mean uterine volume postoperation were lower than preoperation, with statistically significant differences. For patients with dysmenorrhea, the postoperative relief rate was 96.3% (26/27), and for those with excessive menstruation, the postoperative effective rate reached 96.2% (25/26). The main adverse reaction was irregular vaginal bleeding, with an incidence rate of 61.3% (19/31).

CONCLUSION

Hysteroscopic LNG-IUS non-suture fixation at the uterine fundus is a safe and effective technique, particularly suitable for patients with dysmenorrhea, excessive menstruation, or a large uterine cavity who have previously experienced LNG-IUS expulsion. This procedure is simple and minimally invasive, has a short surgical time, has minimal bleeding, and provides rapid recovery; therefore, it is worthy of clinical application.

摘要

目的

本研究旨在探讨一种新型宫腔镜下左炔诺孕酮宫内节育系统(LNG-IUS)子宫底部非缝合固定术的可行性及临床效果。

方法

2023年10月至2024年7月,复旦大学附属妇产科医院开展了一项关于新型宫腔镜下LNG-IUS子宫底部非缝合固定术的前瞻性研究。记录患者的临床症状、手术时间、手术并发症、术后LNG-IUS排出情况及其他随访信息。

结果

本研究共纳入31例患者。子宫平均深度为9.17±0.67cm。其中,10例有LNG-IUS排出史。平均手术时间为13.0±4.1分钟,平均术中出血量为5.3±3.6毫升。所有患者均未发生子宫穿孔、大出血、液体超负荷或术后感染等并发症。术后平均随访时间为6.0±1.8个月,未发生LNG-IUS排出。术后疼痛评估及平均月经量均低于术前,术后子宫内膜厚度及平均子宫体积均低于术前,差异有统计学意义。痛经患者术后缓解率为96.3%(26/27),月经过多患者术后有效率达96.2%(25/26)。主要不良反应为不规则阴道出血,发生率为61.3%(19/31)。

结论

宫腔镜下LNG-IUS子宫底部非缝合固定术是一种安全有效的技术,尤其适用于痛经、月经过多或子宫腔较大且既往有LNG-IUS排出史的患者。该手术操作简单、微创,手术时间短,出血少,恢复快,值得临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6c/12066786/50773a751c02/fmed-12-1563888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6c/12066786/50773a751c02/fmed-12-1563888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca6c/12066786/50773a751c02/fmed-12-1563888-g001.jpg

相似文献

1
Clinical application of a novel hysteroscopic LNG-IUS non-suture fixation at the uterine fundus.新型宫腔镜下左炔诺孕酮宫内缓释系统子宫底部非缝合固定术的临床应用
Front Med (Lausanne). 2025 Apr 28;12:1563888. doi: 10.3389/fmed.2025.1563888. eCollection 2025.
2
Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.宫腔镜下左炔诺孕酮宫内缓释系统缝合固定治疗子宫腺肌病的可行性及有效性。
J Minim Invasive Gynecol. 2024 Jan;31(1):57-63. doi: 10.1016/j.jmig.2023.10.012. Epub 2023 Oct 12.
3
Suture Fixation of Levonorgestrel-Releasing Device Using the Hysteroscopic Surgery System.使用宫腔镜手术系统对左炔诺孕酮释放装置进行缝合固定
JSLS. 2025 Apr-Jun;29(2). doi: 10.4293/JSLS.2024.00076. Epub 2025 Apr 29.
4
The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis.宫腹腔镜冷刀手术系统行左炔诺孕酮宫内节育器缝合固定术治疗子宫腺肌病:一种新方法。
Fertil Steril. 2021 Oct;116(4):1191-1193. doi: 10.1016/j.fertnstert.2021.05.113. Epub 2021 Jul 6.
5
An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.一种创新的手术方法:左炔诺孕酮宫内节育系统的缝合固定术治疗子宫腺肌病
BMC Womens Health. 2022 Nov 16;22(1):451. doi: 10.1186/s12905-022-01932-6.
6
The role of different LNG-IUS therapies in the management of adenomyosis: a systematic review and meta-analysis.不同左炔诺孕酮宫内缓释系统疗法在子宫腺肌病管理中的作用:一项系统评价和荟萃分析。
Reprod Biol Endocrinol. 2025 Feb 13;23(1):23. doi: 10.1186/s12958-025-01349-4.
7
Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.移位左炔诺孕酮宫内节育系统的宫腔镜处理
J Obstet Gynaecol Res. 2013 May;39(5):1014-8. doi: 10.1111/jog.12007. Epub 2013 Mar 17.
8
The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report.左炔诺孕酮宫内节育器缝合固定术治疗子宫腺肌病:一例报告
Int J Surg Case Rep. 2023 Sep;110:108772. doi: 10.1016/j.ijscr.2023.108772. Epub 2023 Sep 1.
9
Efficacy of hysteroscopic levonorgestrel‑releasing intrauterine device fixation in the treatment of adenomyosis: A cohort study.宫腔镜下左炔诺孕酮宫内节育器固定术治疗子宫腺肌病的疗效:一项队列研究。
Biomed Rep. 2024 Jun 4;21(1):109. doi: 10.3892/br.2024.1797. eCollection 2024 Jul.
10
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2015 Apr 30(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.

本文引用的文献

1
Suture-fixation of a levonorgestrel-releasing intrauterine device under hysteroscopic guidance.宫腔镜引导下左炔诺孕酮宫内节育器的缝合固定术。
Facts Views Vis Obgyn. 2023 Dec;15(4):355-358. doi: 10.52054/FVVO.15.4.107.
2
Assessment of key parameters of normal uterus in women of reproductive age.评估育龄期女性正常子宫的关键参数。
Sci Rep. 2023 Oct 18;13(1):17794. doi: 10.1038/s41598-023-44489-6.
3
Feasibility and Effectiveness of Hysteroscopic Suture Fixation of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Adenomyosis.
宫腔镜下左炔诺孕酮宫内缓释系统缝合固定治疗子宫腺肌病的可行性及有效性。
J Minim Invasive Gynecol. 2024 Jan;31(1):57-63. doi: 10.1016/j.jmig.2023.10.012. Epub 2023 Oct 12.
4
Current Medical Therapy for Adenomyosis: From Bench to Bedside.腺肌病的当前医学治疗:从基础到临床。
Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14.
5
The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report.左炔诺孕酮宫内节育器缝合固定术治疗子宫腺肌病:一例报告
Int J Surg Case Rep. 2023 Sep;110:108772. doi: 10.1016/j.ijscr.2023.108772. Epub 2023 Sep 1.
6
Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.子宫内膜上皮内瘤变或不典型子宫内膜增生的管理:ACOG 临床共识 No.5。
Obstet Gynecol. 2023 Sep 1;142(3):735-744. doi: 10.1097/AOG.0000000000005297.
7
Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.高强度聚焦超声(HIFU)、HIFU联合促性腺激素释放激素激动剂(GnRH-a)以及HIFU联合GnRH-a和左炔诺孕酮宫内缓释系统(LNG-IUS)治疗子宫腺肌病的疗效比较:一项系统评价与Meta分析
Taiwan J Obstet Gynecol. 2023 Mar;62(2):226-238. doi: 10.1016/j.tjog.2022.11.009.
8
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis.含左炔诺孕酮的宫内节育系统治疗早期子宫内膜癌的系统评价和荟萃分析。
J Gynecol Oncol. 2023 Mar;34(2):e36. doi: 10.3802/jgo.2023.34.e36. Epub 2023 Jan 18.
9
Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials.左炔诺孕酮宫内节育系统与全身用药或空白对照治疗痛经女性:随机对照试验的系统评价和荟萃分析
Front Glob Womens Health. 2022 Nov 2;3:1013921. doi: 10.3389/fgwh.2022.1013921. eCollection 2022.
10
An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis.一种创新的手术方法:左炔诺孕酮宫内节育系统的缝合固定术治疗子宫腺肌病
BMC Womens Health. 2022 Nov 16;22(1):451. doi: 10.1186/s12905-022-01932-6.